In person
ZoBio was attending TFMED 2026, a four-day transdisciplinary conference dedicated to next-generation therapeutic modalities, including molecular glues, PROTACs, nucleic acid-based therapies, and cell-based approaches.
The meeting brought together researchers, clinicians, and industry experts, offering in-depth scientific sessions, direct interaction with leading specialists, and valuable opportunities for networking and collaboration, with a strong focus on early-career scientists.
Anna Belorusova presented a flash talk and poster titled: “SPR Workflows for Molecular Glue Hit Discovery.”
In her presentation, she highlighted how ZoBio supports molecular glue discovery through dedicated Surface Plasmon Resonance (SPR) workflows, complemented by a suite of orthogonal biophysical techniques. This integrated platform enables direct assessment of protein–protein interactions, supports fragment screening and validation, and provides insights into the likelihood of identifying molecular glues for specific target pairs.
By combining multiple biophysical approaches, we deliver robust characterization and mechanistic understanding of hits, helping to de-risk early-stage discovery and accelerate progress toward challenging targets